Abstract
The ENDOANGEL (EN) computer-assisted detection technique has emerged as a promising tool for enhancing the detection rate of colorectal adenomas during colonoscopies. However, its efficacy in identifying missed adenomas during subsequent colonoscopies remains unclear. Thus, we herein aimed to compare the adenoma miss rate (AMR) between EN-assisted and standard colonoscopies. Data from patients who underwent a second colonoscopy (EN-assisted or standard) within 6 months between September 2022 and May 2023 were analyzed. The EN-assisted group exhibited a significantly higher AMR (24.3% vs 11.9%, P = .005) than the standard group. After adjusting for potential confounders, multivariable analysis revealed that the EN-assisted group had a better ability to detect missed adenomas than the standard group (odds ratio = 2.89; 95% confidence interval = 1.14–7.80, P = .029). These findings suggest that EN-assisted colonoscopy represents a valuable advancement in improving AMR compared with standard colonoscopy. The integration of EN-assisted colonoscopy into routine clinical practice may offer significant benefits to patients requiring hospital resection of lesions following adenoma detection during their first colonoscopy.
Keywords: adenoma miss rate, ENDOANGEL, patients with missed adenomas, second colonoscopy
1. Introduction
Colorectal cancer (CRC) poses a significant global health burden, ranking as the third most prevalent malignant tumor worldwide and the second leading cause of cancer-related deaths.[1] The classical adenoma-carcinoma sequence is the predominant pathway in CRC development, typically unfolding over a 10 to 15 years.[2] This sequence involves the progressive evolution of colorectal adenomas from low-grade dysplasia to high-grade dysplasia and eventually invasive carcinoma.[3] Detecting colorectal adenomas through effective colonoscopy is critical for reducing CRC incidence and mortality rates.[4] Despite its high sensitivity, colonoscopy does not completely prevent future CRC,[5–9] largely due to the failure to detect precancerous lesions,[8,10] leading to the concept of adenoma miss rate (AMR) as a measure of post-colonoscopy CRC risk.[11] Previous studies comparing consecutive colonoscopies have reported miss rates for colorectal lesions ranging from 20% to 40%.[12–14]
The application of computer-aided detection systems based on artificial intelligence (AI) in colonoscopy has shown promise in improving adenoma detection rates and reducing AMR,[15,16] potentially decreasing the risk of interval CRC. One such system, ENDOANGEL (EN), is a novel AI-based detection system developed for the diagnosis and detection of gastrointestinal diseases.[17–19] EN significantly enhances the detection of colorectal adenomas by providing real-time monitoring synchronized with colonoscopy.[20] Additionally, short-term secondary colonoscopies (within 1 year) have been shown to detect an additional approximately 15% of missed colorectal adenomas.[21,22] However, it remains unclear whether EN-assisted colonoscopy can further reduce AMR compared with standard colonoscopy during a second colonoscopy. Therefore, this study aims to investigate whether the use of EN-assisted colonoscopy can improve AMR compared with standard colonoscopy.
2. Patients and methods
2.1. Patients
Patients who underwent a second colonoscopy for polypectomy or endoscopic mucosal resection within 6 months after their first colonoscopy at Yijishan Hospital of Wannan Medical College between September 2022 and May 2023 were retrospectively analyzed. The first colonoscopy was performed as either a surveillance or screening colonoscopy using standard techniques. The second colonoscopy utilized either EN-assisted colonoscopy (EN group) or standard colonoscopy (ST group). If a diminutive lesion was identified during the first colonoscopy, it was removed with the patients’ informed consent. However, if patients had multiple lesions requiring polypectomy or endoscopic mucosal resection, a second colonoscopy was performed after admission. The exclusion criteria comprised age under 18 years, presence of polyposis syndrome, inflammatory bowel disease, CRC, history of colorectal resection, known or suspected intestinal obstruction or perforation, and a total score on the Boston Bowel Preparation Scale (BBPS) of <6 points or any segment with a score of <2 points. The BBPS score was used to evaluate the quality of bowel preparation during withdrawal.[23] Two experienced senior endoscopists, each having performed over 2500 EN-assisted colonoscopies, conducted the colonoscopies using an Olympus Optical colonoscope (GIF-H290, Tokyo, Japan).[20] The bowel was prepared using polyethylene glycol-electrolyte split-dose, following the provided instructions. All patients received sedation with propofol or midazolam and fentanyl.[11] Adenomas were classified as either tubular or (tubulo) villous lesions based on histological examination, with sessile serrated lesions included in the adenoma group. Basic demographic information, abdominal or pelvic surgery history, insertion time, withdrawal time, and BBPS score were recorded. Ethics approval and informed consent were waived by the Ethics Institution of Yijishan Hospital of Wannan Medical College in compliance with national legislation and institutional requirements.
2.2. Confounding variables and study outcome
This study considered several confounding variables, including sex (female/male), age, BBPS score, history of abdominal or pelvic surgery (no/yes), and withdrawal time. The study’s primary outcome was AMR, defined as the number of adenomas detected during the second colonoscopy divided by the total number of adenomas detected during both the first and second colonoscopies.[11]
2.3. Statistical analysis
Continuous variables were reported as means ± standard deviation or as a median with interquartile range (25th–75th percentiles). They were compared using Student t test or the Mann–Whitney U test. Categorical variables were presented as frequencies and percentages and analyzed using the chi-square test or Fisher exact test. Multivariable logistic regression was used to assess the performance of EN-assisted colonoscopy compared with standard colonoscopy in detecting patients with missed adenomas. Statistical analysis was conducted using SPSS 26.0 (SPSS Inc, Chicago, IL) and R version 4.0.2 (The R Foundation for Statistical Computing, Vienna, Austria), with a significance level set at P < .05.
3. Results
3.1. Baseline characteristics
A total of 118 eligible patients were retrospectively included. Table 1 and Table S1, Supplemental Digital Content, http://links.lww.com/MD/N210 present the distribution of patient characteristics and baseline colonoscopy characteristics, classified based on the methods used during the second colonoscopy, respectively. Except for the BBPS score and withdrawal time, no significant differences were noted in all variables between the 2 groups.
Table 1.
Characteristics of patients received a second standard or ENDOANGEL-assisted (EN) colonoscopy.
| Characteristics | Standard (n = 62) | EN (n = 54) | P value |
|---|---|---|---|
| Sex, n (%) | .150 | ||
| Female | 37 (59.7) | 25 (46.3) | |
| Male | 25 (40.3) | 29 (53.7) | |
| Age, mean (SD) | 55.8 (±12.9) | 57.0 (±12.3) | .597 |
| Withdrawal time (min), median (IQR) | 6.7 (6.4–7.2) | 6.3 (6.2–6.7) | <.001 |
| Insertion time (min), median (IQR) | 4.1 (3.3–4.9) | 4.0 (3.3–5.0) | .744 |
| BBPS score, median (IQR) | 9 (8–9) | 8 (7–9) | .014 |
| History of abdominal surgery, n (%) | .447 | ||
| No | 35 (56.5) | 35 (64.8) | |
| Yes | 27 (43.5) | 19 (35.2) | |
| Adenoma miss rate, n (%) | 18/152 (11.9) | 35/144 (24.3) | .005 |
| Patients with missed adenoma rate, n (%) | 15/62 (24.2) | 23/54 (42.6) | .035 |
BBPS = Boston Bowel Preparation Scale.
3.2. Characteristics of missed adenomas
Out of the 118 patients, 38 were identified to have missed adenomas during the second colonoscopy, resulting in a patients with missed adenoma rate of 32.2%. This corresponded to a total of 53 colorectal adenomas that were missed, resulting in an AMR of 17.9%. Upon analysis, the EN group had a significantly higher AMR (P = .005) and missed adenoma rate than the ST group (P = .035). The majority of the missed adenomas were located in the right colon, had a size of ≤5 mm, and were predominantly tubular adenomas (Table 2).
Table 2.
Characteristics of missed adenomas.
| Characteristics | Stndard | ENDOANGEL |
|---|---|---|
| Total missed adenomas | 18 | 35 |
| Location | ||
| Right | 13 | 25 |
| Left | 5 | 10 |
| Size | ||
| ≤5 mm | 13 | 28 |
| 6–9 mm | 5 | 7 |
| ≥10 mm | 1 | 0 |
| Pathology | ||
| Tubular | 13 | 31 |
| Tubulovillous | 4 | 2 |
| Sessile serrated lesions | 1 | 2 |
3.3. ENDOANGEL-assisted colonoscopy and detection of missed adenomas
The univariate analysis revealed a significant association between patients who received EN-assisted colonoscopy and a higher likelihood of detecting missed adenomas than those who underwent standard colonoscopy (odds ratio = 2.32, 95% confidence interval = 1.06–5.22, P = .037) (Table 3). The multivariable analysis showed that the EN group also exhibited better performance in terms of detecting missed adenomas than the ST group (odds ratio = 2.89, 95% confidence interval = 1.14–7.80, P = .029).
Table 3.
Multivariate analysis of the influence of ENDOANGEL-assisted colonoscopy versus standard colonoscopy on the detection of patient with missed adenoma.
| Characteristics | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| OR (95% CI) | P value | OR (95% CI) | P value | |
| Sex | .089 | .034 | ||
| Female | Ref | Ref | ||
| Male | 1.98 (0.91–4.40) | 3.24 (1.14–10.21) | ||
| Age (year) | 1.02 (0.99–1.06) | .154 | 1.02 (0.98–1.06) | .280 |
| History of abdominal surgery | .978 | .240 | ||
| No | Ref | Ref | ||
| Yes | 0.99 (0.44–2.18) | 1.89 (0.67–5.68) | ||
| BBPS score | 0.63 (0.38–1.02) | .060 | 0.59 (0.34–1.00) | .054 |
| Withdrawal time (min) | 1.42 (0.65–3.07) | .367 | 3.08 (1.20–8.35) | .022 |
| Methods | .037 | .029 | ||
| Standard | Ref | Ref | ||
| EN | 2.32 (1.06–5.22) | 2.89 (1.14–7.80) | ||
CI = confidence interval, EN = ENDOANGEL, OR = odds ratio.
4. Discussion
This study represents a pioneering analysis of the impact of EN-assisted colonoscopy on AMR. EN-assisted procedures yielded higher patients with missed adenoma rate and AMR than standard colonoscopy. Furthermore, multivariate analysis underscored the significant enhancement in detecting patients with missed adenomas through EN-assisted colonoscopy during subsequent procedures.
Tandem colonoscopy serves as a benchmark for evaluating AMR.[24] Findings from a randomized controlled trial revealed that AI-driven computer-aided detection systems markedly mitigate AMR and the miss rate of sessile serrated lesions, compared with solitary high-definition white light colonoscopy.[25] Additional tandem colonoscopy investigations corroborated these findings by demonstrating a substantial decrease in AMR.[26] Meta-analyses of tandem colonoscopy studies reported an average AMR of 26%.[27] Nonetheless, owing to low patient compliance and the considerable economic burden associated with tandem colonoscopy, these procedures are predominantly confined to research settings and seldom performed in clinical practice.
Adenomas grow <1 mm annually.[28] Consequently, conducting a follow-up colonoscopy within a short time frame is justified to identify missed colorectal adenomas. Dong et al observed an AMR of 15.8% among patients undergoing a second colonoscopy within 1 year of their first procedure.[21] Similarly, Lee et al reported an AMR of 13.4% in patients undergoing a second colonoscopy within 6 months of their first.[22] Our findings align with these studies. Notably, in the EN group, the majority of missed adenomas (80%) measured ≤5 mm, indicating minimal impact on patient prognosis. Consequently, the clinical effectiveness of EN may be less pronounced than anticipated. These preliminary findings necessitate validation through prospective research endeavors.
The capability of EN to detect lesions in real-time, monitor withdrawal speed and time, mitigate human error, and enhance the likelihood of identifying diminutive adenomas that might be missed with visual inspection alone has been underscored.[29] Moreover, EN helps standardize the detection process, minimizing variances in the cognitive and technical skills of endoscopists, thus improving reproducibility, fidelity, and uniformity in lesion detection.[20,30,31] EN significantly enhances the detection of colorectal adenomas by facilitating real-time monitoring synchronized with colonoscopy.[20] Our findings suggest that EN-assisted secondary colonoscopy effectively improves AMR and identify more patients with missed adenomas than standard colonoscopy in patients necessitating hospital resection of lesions after adenoma detection during their first colonoscopy, potentially mitigating the risk of interval CRC.
Nevertheless, our study has several limitations. First, being a retrospective single-center study, it inherently carries the risk of selection bias, particularly since it only included patients undergoing a second colonoscopy within 6 months. Second, certain patient characteristics, such as alcohol and smoking habits, were not available, which could have influenced the outcomes. Third, our results were based on the second colonoscopy within 6 months after the first procedure, possibly overestimating the miss rate due to newly developed lesions. Lastly, our findings necessitate validation through future large-scale multicenter clinical trials.
In conclusion, EN-assisted colonoscopy presents promising prospects for improving AMR and enhancing the detection of patients with missed adenomas compared with standard colonoscopy. We advocate for the integration of EN-assisted colonoscopy into contemporary clinical practice, especially for patients requiring hospital resection of lesions after adenoma detection during their first colonoscopy.
Author contributions
Conceptualization: Chiyi He.
Data curation: Yundong Wang.
Formal analysis: Yundong Wang.
Funding acquisition: Yundong Wang.
Methodology: Yundong Wang, Chiyi He.
Validation: Chiyi He.
Validation: Chiyi He.
Writing – original draft: Yundong Wang.
Writing – review & editing: Chiyi He.
Supplementary Material
Abbreviations:
- AMR
- adenoma miss rate
- BBPS
- Boston Bowel Preparation Scale
- CRC
- colorectal cancer
- EN
- ENDOANGEL
This work was supported by the Wuhu Science and Technology Project (Grant No. 2021rkx2-1).
The authors have no conflicts of interest to disclose.
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Supplemental Digital Content is available for this article.
How to cite this article: Wang Y, He C. ENDOANGEL improves detection of missed colorectal adenomas in second colonoscopy: A retrospective study. Medicine 2024;103:28(e38938).
References
- [1].Hyuna S, Jacques F, Rebecca LS, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. [DOI] [PubMed] [Google Scholar]
- [2].Staton CA, Chetwood AS, Cameron IC, Cross SS, Brown NJ, Reed MWR. The angiogenic switch occurs at the adenoma stage of the adenoma carcinoma sequence in colorectal cancer. Gut. 2007;56:1426–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [3].Liu H, Wu J, Liu XC, et al. Correlation between microvascular characteristics and the expression of MVD, IGF-1 and STAT3 in the development of colonic polyps carcinogenesis. Exp Ther Med. 2017;13:49–54. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [4].Nishihara R, Wu K, Lochhead P, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013;369:1095–105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [5].Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150:1–8. [DOI] [PubMed] [Google Scholar]
- [6].Cottet V, Jooste V, Fournel I, Bouvier A-M, Faivre J, Bonithon-Kopp C. Long-term risk of colorectal cancer after adenoma removal: a population-based cohort study. Gut. 2012;61:1180–6. [DOI] [PubMed] [Google Scholar]
- [7].Kahi CJ, Imperiale TF, Juliar BE, Rex DK. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin Gastroenterol Hepatol. 2009;7:770–5; quiz 711. [DOI] [PubMed] [Google Scholar]
- [8].Robertson DJ, Lieberman DA, Winawer SJ, et al. Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut. 2013;63:949–56. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [9].Zauber AG, Winawer SJ, O’Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687–96. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [10].Pohl H, Robertson DJ. Colorectal cancers detected after colonoscopy frequently result from missed lesions. Clin Gastroenterol Hepatol. 2010;8:858–64. [DOI] [PubMed] [Google Scholar]
- [11].Dik VK, Gralnek IM, Segol O, et al. Multicenter, randomized, tandem evaluation of EndoRings colonoscopy--results of the CLEVER study. Endoscopy. 2015;47:1151–8. [DOI] [PubMed] [Google Scholar]
- [12].van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, van Deventer SJ, Dekker E. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol. 2006;101:343–50. [DOI] [PubMed] [Google Scholar]
- [13].Gralnek IM, Siersema PD, Halpern Z, et al. Standard forward-viewing colonoscopy versus full-spectrum endoscopy: an international, multicentre, randomised, tandem colonoscopy trial. Lancet Oncol. 2014;15:353–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [14].Leufkens AM, DeMarco DC, Rastogi A, et al. Third Eye Retroscope Randomized Clinical Evaluation [TERRACE] Study Group. Effect of a retrograde-viewing device on adenoma detection rate during colonoscopy: the TERRACE study. Gastrointest Endosc. 2011;73:480–9. [DOI] [PubMed] [Google Scholar]
- [15].Maida M, Marasco G, Facciorusso A, et al. Effectiveness and application of artificial intelligence for endoscopic screening of colorectal cancer: the future is now. Expert Rev Anticancer Ther. 2023;23:719–29. [DOI] [PubMed] [Google Scholar]
- [16].Sinagra E, Badalamenti M, Maida M, et al. Use of artificial intelligence in improving adenoma detection rate during colonoscopy: might both endoscopists and pathologists be further helped. World J Gastroenterol. 2020;26:5911–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [17].Wang J, Wang Z, Chen M, et al. An interpretable artificial intelligence system for detecting risk factors of gastroesophageal variceal bleeding. NPJ Digit Med. 2022;5:183. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [18].Du H, Dong Z, Wu L, et al. A deep-learning based system using multi-modal data for diagnosing gastric neoplasms in real-time (with video). Gastric Cancer. 2023;26:275–85. [DOI] [PubMed] [Google Scholar]
- [19].Wu L, He X, Liu M, et al. Evaluation of the effects of an artificial intelligence system on endoscopy quality and preliminary testing of its performance in detecting early gastric cancer: a randomized controlled trial. Endoscopy. 2021;53:1199–207. [DOI] [PubMed] [Google Scholar]
- [20].Gong D, Wu L, Zhang J, et al. Detection of colorectal adenomas with a real-time computer-aided system (ENDOANGEL): a randomised controlled study. Lancet Gastroenterol Hepatol. 2020;5:352–61. [DOI] [PubMed] [Google Scholar]
- [21].Haibin D, Yutang R, Bo J. Risk factors associated with missed colorectal lesions in colonoscopy and impact of colonoscopy with anesthesia on miss rate. Scand J Gastroenterol. 2021;56:484–91. [DOI] [PubMed] [Google Scholar]
- [22].Jeonghun L, Sung WP, You SK, et al. Risk factors of missed colorectal lesions after colonoscopy. Medicine (Baltim). 2017;96:e7468. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [23].Lai EJ, Calderwood AH, Doros G, Fix OK, Jacobson BC. The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented research. Gastrointest Endosc. 2009;69:620–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [24].Lee HS, Jeon SW, Park HY, Yeo SJ. Improved detection of right colon adenomas with additional retroflexion following two forward-view examinations: a prospective study. Endoscopy. 2017;49:334–41. [DOI] [PubMed] [Google Scholar]
- [25].Glissen Brown JR, Mansour NM, Wang P, et al. Deep learning computer-aided polyp detection reduces adenoma miss rate: a United States multi-center randomized tandem colonoscopy study (CADeT-CS Trial). Clin Gastroenterol Hepatol. 2022;20:1499–507.e4. [DOI] [PubMed] [Google Scholar]
- [26].Wallace MB, Sharma P, Bhandari P, et al. Impact of artificial intelligence on miss rate of colorectal neoplasia. Gastroenterology. 2022;163:295–304.e5. [DOI] [PubMed] [Google Scholar]
- [27].Zhao S, Wang S, Pan P, et al. Magnitude, risk factors, and factors associated with adenoma miss rate of tandem colonoscopy: a systematic review and meta-analysis. Gastroenterology. 2019;156:1661–74.e11. [DOI] [PubMed] [Google Scholar]
- [28].Hofstad B, Vatn MH, Andersen SN, et al. Growth of colorectal polyps: redetection and evaluation of unresected polyps for a period of three years. Gut. 1996;39:449–56. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [29].Xu H, Tang RSY, Lam TYT, et al. Artificial intelligence-assisted colonoscopy for colorectal cancer screening: a multicenter randomized controlled trial. Clin Gastroenterol Hepatol. 2023;21:337–46.e3. [DOI] [PubMed] [Google Scholar]
- [30].Wang P, Berzin TM, Glissen BJR, et al. Real-time automatic detection system increases colonoscopic polyp and adenoma detection rates: a prospective randomised controlled study. Gut. 2019;68:1813–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [31].Repici A, Spadaccini M, Antonelli G, et al. Artificial intelligence and colonoscopy experience: lessons from two randomised trials. Gut. 2022;71:757–65. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
